It was shown that acute or chronic administration of a selective AT2 receptor blocker or selective AT2 receptor stimulator did not alter circulating and intrarenal concentrations of ANG II and, in particular, did not modify the course of hypertension in 2K1C Goldblatt animals. This evidence concerns the gene AGT and hypertensive disorder.